Kestra Advisory Services LLC Has $1.55 Million Position in Celsius Holdings Inc. $CELH

Key Points

• Kestra Advisory Services LLC decreased its holdings in Celsius Holdings Inc. by 10.6%, now owning 43,376 shares valued at approximately $1.5 million.
• Despite this reduction, institutional investors hold approximately 60.95% of Celsius stock, with several firms increasing their stakes during the same period.
• Celsius reported a significant 83.9% year-over-year revenue increase of $739.3 million and earnings per share of $0.47, surpassing analyst expectations.

Kestra Advisory Services LLC decreased its position in shares of Celsius Holdings Inc. (NASDAQ:CELH - Free Report) by 10.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 43,376 shares of the company's stock after selling 5,144 shares during the quarter. Kestra Advisory Services LLC's holdings in Celsius were worth $1,545,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Triumph Capital Management boosted its holdings in shares of Celsius by 41.5% during the fourth quarter. Triumph Capital Management now owns 40,420 shares of the company's stock valued at $1,065,000 after acquiring an additional 11,863 shares during the period. Fifth Third Bancorp lifted its holdings in Celsius by 62.9% in the first quarter. Fifth Third Bancorp now owns 1,725 shares of the company's stock worth $61,000 after purchasing an additional 666 shares during the period. GAMMA Investing LLC lifted its holdings in Celsius by 4,164.4% in the first quarter. GAMMA Investing LLC now owns 73,092 shares of the company's stock worth $2,604,000 after purchasing an additional 71,378 shares during the period. Oppenheimer & Co. Inc. lifted its holdings in Celsius by 14.0% in the first quarter. Oppenheimer & Co. Inc. now owns 9,760 shares of the company's stock worth $348,000 after purchasing an additional 1,199 shares during the period. Finally, Cambridge Investment Research Advisors Inc. lifted its holdings in Celsius by 21.4% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 45,517 shares of the company's stock worth $1,621,000 after purchasing an additional 8,009 shares during the period. Institutional investors and hedge funds own 60.95% of the company's stock.

Insiders Place Their Bets

In other news, CFO Jarrod Langhans sold 5,000 shares of the company's stock in a transaction dated Monday, August 18th. The stock was sold at an average price of $60.00, for a total value of $300,000.00. Following the transaction, the chief financial officer owned 104,227 shares in the company, valued at $6,253,620. This represents a 4.58% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, major shareholder William H. Milmoe sold 300,000 shares of the company's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $47.27, for a total value of $14,181,000.00. Following the completion of the transaction, the insider owned 18,017,770 shares in the company, valued at $851,699,987.90. This represents a 1.64% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,116,141 shares of company stock worth $52,541,605 over the last quarter. Company insiders own 2.20% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Stephens reaffirmed an "overweight" rating on shares of Celsius in a report on Monday, August 11th. Truist Financial upped their price objective on shares of Celsius from $55.00 to $65.00 and gave the stock a "buy" rating in a report on Monday, August 11th. Piper Sandler upped their price objective on shares of Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a report on Wednesday, June 4th. Maxim Group upped their price objective on shares of Celsius from $50.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Finally, Wells Fargo & Company boosted their price target on shares of Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 4th. Seventeen equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Celsius has a consensus rating of "Moderate Buy" and an average target price of $59.37.

Celsius Price Performance

NASDAQ CELH traded down $0.26 on Thursday, reaching $60.84. The company's stock had a trading volume of 2,759,714 shares, compared to its average volume of 8,070,989. Celsius Holdings Inc. has a twelve month low of $21.10 and a twelve month high of $63.50. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 2.11. The stock has a market cap of $15.69 billion, a PE ratio of 163.99, a PEG ratio of 1.43 and a beta of 1.34. The firm's 50 day moving average is $50.76 and its two-hundred day moving average is $40.52.

Celsius (NASDAQ:CELH - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.47 EPS for the quarter, beating analysts' consensus estimates of $0.23 by $0.24. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The company had revenue of $739.30 million during the quarter, compared to analyst estimates of $632.13 million. During the same period in the prior year, the firm earned $0.28 earnings per share. The business's quarterly revenue was up 83.9% on a year-over-year basis. As a group, sell-side analysts predict that Celsius Holdings Inc. will post 0.89 EPS for the current year.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.